DuoResp Spiromax (formoterol budesonide): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

DuoResp Spiromax 160 micrograms / 4.5 micrograms inhalation powder

DuoResp Spiromax is indicated in adults 18 years of age and older only.

Asthma

DuoResp Spiromax is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:

-in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.

or

-in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.

COPD

Symptomatic treatment of patients with COPD with forced expiratory volume in 1 second (FEV1) < 70% predicted normal and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

DuoResp Spiromax 320 micrograms/9 micrograms inhalation powder

DuoResp Spiromax is indicated in adults 18 years of age and older only.

Asthma

DuoResp Spiromax is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:

- in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.

or

- in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.

COPD

Symptomatic treatment of patients with COPD with forced expiratory volume in 1 second (FEV1) < 70% predicted normal and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.


Route of administration: opinion.traitement.inhalation
Molecule: formoterol, budesonide

Patients' opinions on DuoResp Spiromax

In brief

General satisfaction level: 3.00/10 Learn more

Treatment's effectiveness: 2.00/10 Learn more

Ease of use: 9.00/10 Learn more

Adherence to prescription: 7.00/10 Learn more

Detected side effects: Be the first to evaluate

Improvement in the quality of life: 2.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community


avatar
Marquita
on 04/01/2022

Not happy with it. It is not stopping the weasing.

Your message

Conditions related to this medication

Fact sheet

COPD

See the fact sheet
Fact sheet

Asthma

See the fact sheet